Kirk J. Wangensteen

4.2k total citations · 1 hit paper
58 papers, 2.1k citations indexed

About

Kirk J. Wangensteen is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Kirk J. Wangensteen has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Kirk J. Wangensteen's work include Liver physiology and pathology (15 papers), Liver Disease Diagnosis and Treatment (11 papers) and CRISPR and Genetic Engineering (9 papers). Kirk J. Wangensteen is often cited by papers focused on Liver physiology and pathology (15 papers), Liver Disease Diagnosis and Treatment (11 papers) and CRISPR and Genetic Engineering (9 papers). Kirk J. Wangensteen collaborates with scholars based in United States, China and France. Kirk J. Wangensteen's co-authors include Klaus H. Kaestner, Yue J. Wang, Stephen C. Ekker, Loree K. Kalliainen, Michal Shoshkes-Carmel, Shalev Itzkovitz, Ayano Kondo, Beáta Tóth, Efi E. Massasa and Darius Balčiūnas and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Genes & Development.

In The Last Decade

Kirk J. Wangensteen

55 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Subepithelial telocytes are an important source of Wnts that supports intestinal crypts

2018 366 citations Michal Shoshkes-Carmel, Yue J. Wang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk J. Wangensteen United States	25	1.2k	472	419	412	357	58	2.1k
Stacey S. Huppert United States	20	1.4k 1.1×	484 1.0×	262 0.6×	343 0.8×	244 0.7×	44	2.2k
S. Tamir Rashid United Kingdom	20	1.7k 1.4×	520 1.1×	289 0.7×	352 0.9×	198 0.6×	30	2.3k
Christophe E. Pierreux Belgium	32	1.9k 1.6×	1.2k 2.6×	676 1.6×	576 1.4×	440 1.2×	83	3.5k
Matt Fish United States	10	991 0.8×	428 0.9×	121 0.3×	470 1.1×	161 0.5×	13	1.5k
William G. Taylor United States	21	1.5k 1.2×	343 0.7×	248 0.6×	437 1.1×	345 1.0×	39	2.3k
Janaiah Kota United States	16	2.5k 2.1×	231 0.5×	375 0.9×	188 0.5×	370 1.0×	27	3.3k
Anja Runge Germany	15	950 0.8×	236 0.5×	114 0.3×	229 0.6×	116 0.3×	15	1.7k
Gerald R. Hankins United States	21	846 0.7×	302 0.6×	307 0.7×	84 0.2×	246 0.7×	41	1.7k
Bibhuti Mishra United States	20	1.0k 0.8×	195 0.4×	86 0.2×	241 0.6×	526 1.5×	38	1.6k
Yohei Hirai Japan	22	1.2k 1.0×	209 0.4×	209 0.5×	115 0.3×	440 1.2×	71	2.0k

Countries citing papers authored by Kirk J. Wangensteen

Since Specialization

Citations

This map shows the geographic impact of Kirk J. Wangensteen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk J. Wangensteen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk J. Wangensteen more than expected).

Fields of papers citing papers by Kirk J. Wangensteen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk J. Wangensteen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk J. Wangensteen. The network helps show where Kirk J. Wangensteen may publish in the future.

Co-authorship network of co-authors of Kirk J. Wangensteen

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk J. Wangensteen. A scholar is included among the top collaborators of Kirk J. Wangensteen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk J. Wangensteen. Kirk J. Wangensteen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armasu, Sebastian M., Irene K. Yan, Fowsiyo Ahmed, et al.. (2025). Association of Epigenetic Aging Biomarkers With Risk of MASLD ‐Related HCC. Liver International. 46(1). e70464–e70464.

Vanderboom, Patrick M., et al.. (2024). Iron and Copper Liver Concentrations in Wilson Disease. Journal of Gastrointestinal and Liver Diseases. 33(4). 517–523. 1 indexed citations

Loomba, Rohit, Arunkumar Krishnan, Kirk J. Wangensteen, et al.. (2023). Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality. JAMA Network Open. 6(6). e2320222–e2320222. 59 indexed citations

Krishnan, Arunkumar, Kirk J. Wangensteen, Marina Serper, et al.. (2023). Aspirin is associated with a reduced incidence of liver disease in men. Hepatology Communications. 7(10). 7 indexed citations

Lau‐Min, Kelsey S., Danielle McKenna, Jessica M. Long, et al.. (2023). Development of an Electronic Health Record–Based Clinical Decision Support Tool for Patients With Lynch Syndrome. JCO Clinical Cancer Informatics. 7(7). e2300024–e2300024. 1 indexed citations

Saito, Yoshinobu, Naoto Kubota, Xiaobo Wang, et al.. (2023). A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. Gastroenterology. 164(7). 1279–1292. 40 indexed citations

Preziosi, Morgan, Dali Yin, Ágnes Holczbauer, et al.. (2022). In Vivo Screen Identifies Liver X Receptor Alpha Agonism Potentiates Sorafenib Killing of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 1(5). 905–908. 6 indexed citations

Grattarola, Margherita, Ágnes Holczbauer, Rosanna Dono, et al.. (2022). MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities. Cell Death and Disease. 13(11). 994–994. 18 indexed citations

Vajravelu, Ravy K., et al.. (2021). Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome. World Journal of Clinical Oncology. 12(11). 1023–1036. 1 indexed citations

10.

Holczbauer, Ágnes, Kirk J. Wangensteen, & Soona Shin. (2021). Cellular origins of regenerating liver and hepatocellular carcinoma. JHEP Reports. 4(4). 100416–100416. 26 indexed citations

11.

Zahm, Adam M., Amber W. Wang, Yue J. Wang, et al.. (2019). A High-Content Screen Identifies MicroRNAs That Regulate Liver Repopulation After Injury in Mice. Gastroenterology. 158(4). 1044–1057.e17. 11 indexed citations

12.

Wang, Amber W., Kirk J. Wangensteen, Yue J. Wang, et al.. (2018). TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury. Journal of Clinical Investigation. 128(6). 2297–2309. 22 indexed citations

13.

Mahmud, Nadim & Kirk J. Wangensteen. (2018). Endoscopic Band Ligation to Treat a Massive Hemorrhoidal Hemorrhage Following a Transrectal Ultrasound-Guided Prostate Biopsy. Annals of Coloproctology. 34(1). 47–51. 1 indexed citations

14.

Shoshkes-Carmel, Michal, Yue J. Wang, Kirk J. Wangensteen, et al.. (2018). Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature. 557(7704). 242–246. 366 indexed citations breakdown →

15.

Wangensteen, Kirk J., Yue J. Wang, Zhixun Dou, et al.. (2017). Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform†. Hepatology. 68(2). 663–676. 61 indexed citations

16.

Wangensteen, Kirk J., et al.. (2016). Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 61(9). 2710–2720. 59 indexed citations

17.

Wang, Minjun, Fei Chen, Jianxiu Li, et al.. (2014). Reversal of Hepatocyte Senescence After Continuous In Vivo Cell Proliferation. Hepatology. 60(1). 349–361. 76 indexed citations

18.

Wilber, Andrew, Kirk J. Wangensteen, Yixin Chen, et al.. (2007). Messenger RNA as a Source of Transposase for Sleeping Beauty Transposon–mediated Correction of Hereditary Tyrosinemia Type I. Molecular Therapy. 15(7). 1280–1287. 61 indexed citations

19.

Balčiūnas, Darius, Kirk J. Wangensteen, Andrew Wilber, et al.. (2006). Harnessing a High Cargo-Capacity Transposon for Genetic Applications in Vertebrates. PLoS Genetics. 2(11). e169–e169. 260 indexed citations

20.

Sivasubbu, Sridhar, Darius Balčiūnas, Ann E. Davidson, et al.. (2006). Gene-breaking transposon mutagenesis reveals an essential role for histone H2afza in zebrafish larval development. Mechanisms of Development. 123(7). 513–529. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact